NASDAQ:NVCR NovoCure - NVCR Insider Trading & Ownership Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovoCure Limited Please log in to your account or sign up in order to add this asset to your watchlist. $60.14 +1.90 (+3.26%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$58.34▼$60.9750-Day Range$56.44▼$95.0952-Week Range$56.06▼$120.03Volume577,188 shsAverage Volume764,206 shsMarket Capitalization$6.34 billionP/E RatioN/ADividend YieldN/APrice Target$87.33 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability NovoCure (NASDAQ:NVCR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.22%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$28.17 M NVCR Insider Buying and Selling by Quarter Get NVCR Insider Trade Alerts Want to know when executives and insiders are buying or selling NovoCure stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NovoCure Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails3/3/2023Frank X LeonardInsiderSell2,059$77.64$159,860.7667,893 3/1/2023Ashley CordovaCFOSell2,198$76.36$167,839.2896,062 3/1/2023Frank X LeonardInsiderSell1,684$76.36$128,590.2463,095 3/1/2023Wilhelmus Cm GroenhuysenCOOSell2,164$76.36$165,243.04184,615 1/5/2023Asaf DanzigerCEOSell212,500$108.74$23,107,250.0013,583 1/5/2023Uri WeinbergInsiderSell8,143$116.14$945,728.0243,286 10/13/2022Frank X LeonardInsiderSell6,754$76.01$513,371.5443,626 10/6/2022Frank X LeonardInsiderSell6,754$84.37$569,834.9850,380 9/29/2022Frank X LeonardInsiderSell6,754$77.35$522,421.9057,134 9/22/2022Frank X LeonardInsiderSell6,754$77.00$520,058.0063,888 9/15/2022Frank X LeonardInsiderSell12,271$88.52$1,086,228.9270,642 9/9/2022Frank X LeonardInsiderSell1,863$88.00$163,944.0084,150 8/2/2022Ely BenaimInsiderSell437$69.66$30,441.4234,631 8/2/2022William F DoyleChairmanSell837$69.66$58,305.42551,176 6/10/2022Jeryl L HillemanDirectorSell407$69.61$28,331.272,537 (Data available from 1/1/2013 forward) NVCR Insider Trading Activity - Frequently Asked Questions Who is on NovoCure's Insider Roster? The list of insiders at NovoCure includes Asaf Danziger, Ashley Cordova, Ely Benaim, Frank X Leonard, Gabriel Leung, Jeryl L Hilleman, Martin J Madden, Michael J Ambrogi, Pritesh Shah, Todd Christopher Longsworth, Uri Weinberg, Wilhelmus Cm Groenhuysen, and William F Doyle. Learn more on insiders at NVCR. What percentage of NovoCure stock is owned by insiders? 6.22% of NovoCure stock is owned by insiders. Learn more on NVCR's insider holdings. Which NovoCure insiders have been buying company stock? The following insider purchased NVCR shares in the last 24 months: Asaf Danziger ($509,536.56). How much insider buying is happening at NovoCure? Insiders have purchased a total of 4,974 NVCR shares in the last 24 months for a total of $509,536.56 bought. Which NovoCure insiders have been selling company stock? The following insiders have sold NVCR shares in the last 24 months: Asaf Danziger ($42,343,268.82), Ashley Cordova ($4,173,486.68), Ely Benaim ($2,119,820.51), Frank X Leonard ($3,733,595.34), Gabriel Leung ($1,780,800.00), Jeryl L Hilleman ($28,331.27), Martin J Madden ($5,206.42), Pritesh Shah ($6,254,856.84), Todd Christopher Longsworth ($245,466.90), Uri Weinberg ($945,728.02), Wilhelmus Cm Groenhuysen ($492,089.47), and William F Doyle ($19,182,743.92). How much insider selling is happening at NovoCure? Insiders have sold a total of 561,306 NovoCure shares in the last 24 months for a total of $81,380,038.39 sold. This page (NASDAQ:NVCR) was last updated on 4/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.